04/24/2024
7:53 PM | Centessa Pharmaceuticals (Filer)
| Form 424B5 | |
04/24/2024
8:26 AM | Centessa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/23/2024
4:16 PM | Centessa Pharmaceuticals (Filer)
| Form 424B5 | |
04/22/2024
6:15 AM | Centessa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/02/2024
3:17 PM | Centessa Pharmaceuticals (Issuer)
SAHA SAURABH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2024
3:15 PM | Bush Tia L (Reporting)
Centessa Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2024
3:16 PM | Centessa Pharmaceuticals (Issuer)
HUSSAIN IQBAL J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
03/28/2024
3:44 PM | Centessa Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/26/2024
3:16 PM | Anderson Karen M. (Reporting)
Centessa Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/25/2024
3:06 PM | Anderson Karen M. (Reporting)
Centessa Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/14/2024
4:37 PM | Centessa Pharmaceuticals (Subject)
EcoR1 Capital, LLC (Filed by)
| Form SC 13G/A | |
02/09/2024
6:12 AM | Centessa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/02/2024
4:10 PM | Centessa Pharmaceuticals (Issuer)
CHAO DAVID M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
4:02 PM | Anderson Karen M. (Reporting)
Centessa Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
4:03 PM | Centessa Pharmaceuticals (Issuer)
Rotman Harris (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
4:04 PM | Bush Tia L (Reporting)
Centessa Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
4:07 PM | Centessa Pharmaceuticals (Issuer)
SAHA SAURABH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
4:08 PM | Centessa Pharmaceuticals (Issuer)
Weinhoff Gregory M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
4:09 PM | Centessa Pharmaceuticals (Issuer)
HUSSAIN IQBAL J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/09/2024
6:56 AM | Centessa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/09/2024
6:56 AM | Centessa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/02/2024
6:41 PM | Centessa Pharmaceuticals (Issuer)
GRAINGER DAVID J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2024
6:43 PM | Centessa Pharmaceuticals (Issuer)
SAHA SAURABH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2024
6:44 PM | Centessa Pharmaceuticals (Issuer)
HUSSAIN IQBAL J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2024
6:45 PM | Centessa Pharmaceuticals (Issuer)
Weinhoff Gregory M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2024
6:46 PM | Centessa Pharmaceuticals (Issuer)
CHAO DAVID M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2024
6:37 PM | Bush Tia L (Reporting)
Centessa Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2023
6:05 AM | Centessa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/25/2023
8:49 AM | Centessa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/03/2023
3:46 PM | Bush Tia L (Reporting)
Centessa Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/22/2023
3:47 PM | Centessa Pharmaceuticals (Issuer)
Rotman Harris (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/20/2023
3:02 PM | Centessa Pharmaceuticals (Subject)
Rotman Harris (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/01/2023
3:31 PM | Centessa Pharmaceuticals (Subject)
YVER ANTOINE (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/14/2023
6:06 AM | Centessa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2023
6:18 AM | Centessa Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/10/2023
4:00 PM | Centessa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/03/2023
4:34 PM | Centessa Pharmaceuticals (Issuer)
HUSSAIN IQBAL J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2023
4:35 PM | Centessa Pharmaceuticals (Issuer)
CHAO DAVID M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2023
4:29 PM | Bush Tia L (Reporting)
Centessa Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2023
4:31 PM | Centessa Pharmaceuticals (Issuer)
GRAINGER DAVID J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2023
4:32 PM | Centessa Pharmaceuticals (Issuer)
SAHA SAURABH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Forget AI, Imperium Is Expected to Grow 320,00% in 3 Years (Ad) If you think AI is big, then you have got to check out something I call Imperium…
By my calculations, it’s set to grow 320,000% in three years. (You can see my calculations here.) Watch my video for all of the details |
07/03/2023
4:33 PM | Centessa Pharmaceuticals (Issuer)
Weinhoff Gregory M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2023
12:43 PM | Centessa Pharmaceuticals (Subject)
YVER ANTOINE (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/26/2023
6:03 PM | Centessa Pharmaceuticals (Issuer)
General Atlantic S.a r.l. (0001858361) (Reporting)
General Atlantic Cooperatief U.A. (Reporting)
General Atlantic Cooperatief, L.P. (Reporting)
General Atlantic UM B.V. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2023
4:05 PM | Centessa Pharmaceuticals (Issuer)
Hukkelhoven Mathias (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2023
4:07 PM | Centessa Pharmaceuticals (Issuer)
Kulkarni Samarth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2023
4:08 PM | Centessa Pharmaceuticals (Issuer)
Stuckley Carol (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2023
4:09 PM | Centessa Pharmaceuticals (Issuer)
ZBAR BRETT I W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2023
4:01 PM | Centessa Pharmaceuticals (Issuer)
Rotman Harris (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
06/23/2023
4:02 PM | Centessa Pharmaceuticals (Issuer)
GOYAL ARJUN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2023
4:03 PM | Centessa Pharmaceuticals (Issuer)
Hedley Mary Lynne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/22/2023
3:05 PM | Centessa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/09/2023
6:10 AM | Centessa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/24/2023
4:06 PM | Bush Tia L (Reporting)
Centessa Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/23/2023
3:08 PM | Centessa Pharmaceuticals (Filer)
| Form DEFA14A | |
05/22/2023
6:06 AM | Centessa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2023
7:00 AM | Centessa Pharmaceuticals (Filer)
| Form ARS | |
05/15/2023
7:01 AM | Centessa Pharmaceuticals (Filer)
| Form DEF 14A | |
05/12/2023
6:04 AM | Centessa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/12/2023
6:14 AM | Centessa Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
